Skip to content

RLAY

Relay Therapeutics, Inc.

Stock

$18.96+0.47 (+2.54%)Close Oct 2, 2026

Shareholders' equity, 2025
$567M
YoY, 2025
−27.1%
5-year CAGR
−5.8%

Shareholders' equity

Shareholders' equity by fiscal year

PeriodEquityYoY
2025$567M−27.1%
2024$778M+3.4%
2023$752M−20.9%
2022$950M+5.8%
2021$898M+17.6%
2020$763M—
2019−$180M—